Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

25201
1
Clearside Biomedical, Inc. Clearside Biomedical Reports $34.4 Million Net Loss and Decreased Revenue for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25202
1
ZION OIL & GAS INC Zion Oil & Gas Reports $7.34 Million Net Loss for Fiscal Year 2024, Receives New Exploration License

Via official filing (AI summary) | about 1 year ago | 0 comments

25203
1
Pony Group Inc. Pony Group Inc. Reports 45% Revenue Decline and Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25204
1
SK Growth Opportunities Corp SK Growth Opportunities Corp. Reports $3.2M Net Income for 2024, Signs Business Combination Agreement with Webull

Via official filing (AI summary) | about 1 year ago | 0 comments

25205
1
Spero Therapeutics, Inc. Spero Therapeutics Reports $68.6 Million Net Loss for 2024, Decreased Collaboration Revenue

Via official filing (AI summary) | about 1 year ago | 0 comments

25206
1
FACT II Acquisition Corp. FACT II Acquisition Corp. Reports No Revenue and $71,891 Net Loss for Fiscal Year Ending December 31, 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25207
1
Texas Community Bancshares, Inc. Texas Community Bancshares Reports $1.3 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25208
1
Tyra Biosciences, Inc. Tyra Biosciences Reports $86.48 Million Net Loss for 2024, Increases R&D Spending

Via official filing (AI summary) | about 1 year ago | 0 comments

25209
1
Gain Therapeutics, Inc. Gain Therapeutics Reports $20.4 Million Net Loss for Fiscal Year 2024, No Revenue Generated

Via official filing (AI summary) | about 1 year ago | 0 comments

25210
1
IRIDEX CORP IRIDEX Corporation Reports $48.7 Million Revenue and $8.9 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25211
1
NEXTNRG, INC. NextNRG Reports $16.2 Million Net Loss Despite 19.6% Revenue Growth in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25212
1
Kodiak Sciences Inc. Kodiak Sciences Reports $176.2 Million Net Loss for 2024, Decreased R&D Expenses

Via official filing (AI summary) | about 1 year ago | 0 comments

25213
1
Inhibikase Therapeutics, Inc. Inhibikase Therapeutics Reports $27.5 Million Net Loss for 2024, Increases R&D Spending

Via official filing (AI summary) | about 1 year ago | 0 comments

25214
1
FOOT LOCKER, INC. Foot Locker Reports Decline in Sales but Recovery in Net Income for Fiscal Year Ending February 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

25215
1
FB Bancorp, Inc. /MD/ FB Bancorp Reports $6.2 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25216
1
NEXGEL, INC. NexGel Reports 112.5% Revenue Growth to $8.7 Million in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25217
1
Precipio, Inc. Precipio Reports $4.3 Million Net Loss and 22% Revenue Growth for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25218
1
Kyverna Therapeutics, Inc. Kyverna Therapeutics Reports $127.5M Net Loss for 2024, Driven by Increased R&D Expenses

Via official filing (AI summary) | about 1 year ago | 0 comments

25219
1
Heliogen, Inc. Heliogen Reports $23.2 Million Revenue and $32.5 Million Net Income for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25220
1
Hour Loop, Inc Hour Loop, Inc. Reports 4.6% Revenue Growth and Net Income Turnaround for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25221
1
lululemon athletica inc. Lululemon Reports 10% Revenue Increase to $10.6 Billion for Fiscal Year Ending February 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

25222
1
EMPIRE PETROLEUM CORP Empire Petroleum Corporation Reports $16.2 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25223
1
Co-Diagnostics, Inc. Co-Diagnostics Reports 43% Revenue Decline and Increased Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25224
1
BARFRESH FOOD GROUP INC. Barfresh Food Group Reports 32% Revenue Increase to $10.7 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25225
1
LANDS' END, INC. Lands' End Reports $1.36 Billion Revenue, 7.4% Decrease, but Improved Profitability

Via official filing (AI summary) | about 1 year ago | 0 comments